Sunitinib treatment in patients with advanced renal cell cancer: the Brazilian National Cancer Institute (INCA) experience

PURPOSE: The aim of this study was to assess the impact of sunitinib treatment in a non-screened group of patients with metastatic renal cell cancer (mRCC) treated by the Brazilian Unified Health System (SUS) at a single reference institution. MATERIAL AND METHODS: Retrospective cohort study, which...

Descripción completa

Detalles Bibliográficos
Autores principales: Coelho, Rafael Corrêa, Reinert, Tomás, Campos, Franz, Peixoto, Fábio Affonso, de Andrade, Carlos Augusto, Castro, Thalita, Herchenhorn, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Urologia 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006764/
https://www.ncbi.nlm.nih.gov/pubmed/27564279
http://dx.doi.org/10.1590/S1677-5538.IBJU.2015.0226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006764/
https://www.ncbi.nlm.nih.gov/pubmed/27564279
http://dx.doi.org/10.1590/S1677-5538.IBJU.2015.0226

Ejemplares similares